# A Pilot Study on the Efficacy and Safety of a Novel Synbiotic Formula (SGR11) in Patients With Inflammatory Bowel Disease (IBD)

> **NCT07411131** · NA · NOT_YET_RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 50 (estimated)

## Conditions studied

- Inflammatory Bowel Disease (IBD)
- Ulcerative Colitis (UC)

## Interventions

- **OTHER:** SGR11 synbiotic formula

## Key facts

- **NCT ID:** NCT07411131
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2026-09
- **Final completion:** 2026-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07411131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07411131, "A Pilot Study on the Efficacy and Safety of a Novel Synbiotic Formula (SGR11) in Patients With Inflammatory Bowel Disease (IBD)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07411131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*